OPR - Delayed Quote • USD CDMO Dec 2024 10.000 call (CDMO241220C00010000) Follow 1.2000 +0.2000 (+20.00%) At close: April 26 at 10:44 AM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for CDMO241220C00010000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: CDMO Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results Avid Bioservices Announces Pricing of Private Placement of Convertible Notes Avid Bioservices Announces Proposed Private Placement of Convertible Notes Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 Avid Bioservices (CDMO) Declined in 2023 Insider Stock Buying Reaches US$527.5k On Avid Bioservices Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call Transcript Avid Bioservices Inc (CDMO) Adjusts Fiscal 2024 Revenue Guidance Amidst Second Quarter Challenges Avid Bioservices (CDMO) Reports Q2 Loss, Lags Revenue Estimates
